Innocrin Pharmaceuticals

Innocrin Pharmaceuticals

Novel, best-in-class oral inhibitors of cyp17 lyase, a validated enzyme target for the treatment

Innocrin Pharmaceuticals Company information

Edit
Growth stage
  • Edit
loading funding rounds…

Recent News about Innocrin Pharmaceuticals

Edit
Are you an employee or an investor of this company?
Add your profile